Shilpa Medicare is currently trading at its upper limit of Rs. 515.20, up by 24.50 points or 4.99% from its previous closing of Rs. 490.70 on the BSE.
The scrip opened at Rs. 505.00 and has touched a high and low of Rs. 515.20 and Rs. 499.25 respectively. So far 44229 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 515.20 on 25-Feb-2020 and a 52 week low of Rs. 190.80 on 04-Sep-2019.
Last one week high and low of the scrip stood at Rs. 515.20 and Rs. 450.00 respectively. The current market cap of the company is Rs. 4200.27 crore.
The promoters holding in the company stood at 53.80%, while Institutions and Non-Institutions held 26.89% and 19.31% respectively.
Shilpa Medicare has received approval from its board for the sale of biological unit by way of slump sale to Shilpa Biologicals, a wholly owned subsidiary of the company subject to the approval of shareholders. The biological unit proposed to be sold is under construction/installation stage and not yet commenced commercial operations.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
